Sort
25,944 grants matching “neurodegeneration”
MRI Assessment--Transgenic Models of Alzheimer's Disease
$228,401Nathan S. Kline Institute For Psych Res · P01 · FY2001 · AG
Lysosomal Dysreg &Neurodeg in Alzheimer's Disease
$228,401Nathan S. Kline Institute For Psych Res · P01 · FY2001 · AG
Lysosomal Dysreg &Neurodeg in Alzheimer's Disease
$228,401Nathan S. Kline Institute For Psych Res · P01 · FY2000 · AG
Conditional deletion of Mapt in the adult mouse brain
$228,400Ruben Vidal · Indiana University Indianapolis · R21 · FY2016 · NS
Mechanisms of ATM activation
$228,365Tanya T Paull · University Of Texas At Austin · R01 · FY2013 · CA
The Contribution of Late Onset Unexplained Epilepsy to Cognitive Decline and its Interaction with Vascular and Alzheimer's Disease Pathologies
$228,267Rani Sarkis · Brigham And Women'S Hospital · K23 · FY2024 · NS
Human MicroRNA as a potential therapeutic target in Alzheimer's disease.
$228,204Debomoy K Lahiri · Indiana University Indianapolis · R21 · FY2012 · AG
Alzheimer's Disease Biomarker for Diagnosis and Prognosis
$228,159Amal O Amer · Ohio State University · R21 · FY2020 · AG
TLX Ligands in Neural Stem Cells & Neurodegeneration
$228,150Yanhong Shi · Beckman Research Institute/City Of Hope · R21 · FY2006 · NS
Conditional Models: non-cell-autonomous Toxicities in HD
$228,138Xiangdong William Yang · University Of California Los Angeles · R01 · FY2011 · NS
Understanding the role of BORCS5 in neuronal lysosomal function and neurodegeneration
$228,015Niccolo E Mencacci · Northwestern University At Chicago · K08 · FY2025 · NS
THERAPEUTIC APPROACHES FOR NEURODEGENERATION CAUSED BY PLA2G6 MUTATIONS
$228,000Paul T Kotzbauer · Washington University · R21 · FY2011 · NS
Effects of intracranial rAAV.Neu3 on dementia and neuropathology
$228,000Michael P McDonald · University Of Tennessee Health Sci Ctr · R21 · FY2016 · AG
Macrophage, blood-brain barrier, and modulation of neurodegeneration
$227,997Georgette D. Kanmogne · University Of Nebraska Medical Center · P01 · FY2011 · NS
The Contribution of Late Onset Unexplained Epilepsy to Cognitive Decline and its Interaction with Vascular and Alzheimer's Disease Pathologies
$227,943Rani Sarkis · Brigham And Women'S Hospital · K23 · FY2023 · NS
Age-related epigenetic gene silencing in the RPE
$227,938Leonard Martin Hjelmeland · University Of California At Davis · R21 · FY2006 · EY
ATM SIGNALING AND NEURODEGENERATION
$227,894University Of Texas Hlth Sci Ctr San Ant · R01 · FY2000 · NS
Experimental Therapeutic Strategies for ALS
$227,867Columbia University Health Sciences · P01 · FY2004 · NS
Targeting proteostasis to treat Niemann-Pick C disease
$227,794Andrew P Lieberman · University Of Michigan At Ann Arbor · R21 · FY2012 · NS
PSD-95 in Striatal Neuronal Vulnerability
$227,719Wei-Dong Yao · Harvard Medical School · R21 · FY2008 · NS
Senescent neurons in the human brain: A link between aging and HIV
$227,707Claudio Aurelio Torres · Drexel University · R21 · FY2015 · AG
Immunophilin Ligands and Age-related Cognition
$227,500Guilford Pharmaceuticals, Inc. · R43 · FY2005 · MH
Immunophilin Ligands and Age-related Cognition
$227,500Guilford Pharmaceuticals, Inc. · R43 · FY2004 · MH
Multicultural Community Dementia Screening
$227,366James E Galvin · University Of Miami School Of Medicine · R01 · FY2023 · AG
NanoGenomics to study molecular mechanisms of neurodegeneration in human cells
$227,328Nader Pourmand · University Of California Santa Cruz · R21 · FY2014 · NS